Yanki Yarman: Linking Genetic Variants to Clinical Outcomes in Thrombosis
Yanki Yarman, MD and Ph.D. Student at Sidney Kimmel Medical College, shared a post on LinkedIn about a recent article by Marvin T. Nieman, published in ASH, adding:
“I’m truly touched and honored by this Blood commentary penned by Dr. Marvin Nieman on my PhD project.
I’m especially grateful for his description of our study and its comprehensive methods ‘as a model for future studies aiming to connect genetic variants with molecular mechanisms and clinical outcomes.’
As a physician-scientist in training, I care deeply about genetically screening patients and understanding the molecular pathways underlying their diseases.
I hope to practice personalized medicine in the near future.
Here’s the Blood commentary on the GRK5 variant that we linked to increased thrombotic risk.”
Title: GRK5 polymorphism turns up the volume on PAR1
Auhtors: Marvin Nieman
Stay updated on all scientific advances with Hemostasis Today.
-
Apr 20, 2026, 12:09Syed Sibtain Raza: White Blood Cells – Understanding Morphology for Better Diagnosis
-
Apr 20, 2026, 11:23Bastu Odoka: Jehovah’s Witness News on Transfusion… and a Question Worth Asking
-
Apr 20, 2026, 11:15William Aird: A Physiological Approach to Anemia
-
Apr 20, 2026, 10:59Eric Topol: Is the Interferon Pathway a Key Driver of Inflammaging and Aging
-
Apr 20, 2026, 10:47Emmanuel J Favaloro: Emerging Perspectives on Extracellular Vesicles in Hemophilia
-
Apr 20, 2026, 10:21Pierpaolo Di Micco: Honored to Join the ESVM Congress in Lausanne
-
Apr 20, 2026, 08:17Heghine Khachatryan: Key Takeaways from Day 1 – WFH 2026 World Congress
-
Apr 20, 2026, 08:10Justin Nelson-Deering։ Celebrating World Hemophilia Day in Pediatric Care
-
Apr 20, 2026, 07:53Maha Othman: Students Bringing Biomedical Chemistry to Life Through a Mini Symposium